GSK3359609
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GSK3359609, covering 2022-05-24 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) [Phase 1]